Enovix Corp. (ENVX)
3.32
-0.05
(-1.48%)
USD |
NASDAQ |
Sep 04, 16:00
3.33
+0.01
(+0.30%)
After-Hours: 20:00
Enovix Research and Development Expense (Quarterly) : 24.44M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 24.44M |
| March 31, 2026 | 26.53M |
| December 31, 2025 | 27.66M |
| September 30, 2025 | 28.18M |
| June 30, 2025 | 28.15M |
| March 31, 2025 | 25.93M |
| December 31, 2024 | 22.02M |
| September 30, 2024 | 24.22M |
| June 30, 2024 | 29.06M |
| March 31, 2024 | 36.30M |
| December 31, 2023 | 34.58M |
| September 30, 2023 | 13.51M |
| Date | Value |
|---|---|
| June 30, 2023 | 16.55M |
| March 31, 2023 | 23.75M |
| December 31, 2022 | 15.54M |
| September 30, 2022 | 13.95M |
| June 30, 2022 | 15.83M |
| March 31, 2022 | 12.73M |
| December 31, 2021 | 12.44M |
| September 30, 2021 | 10.30M |
| June 30, 2021 | 9.523M |
| March 31, 2021 | 5.589M |
| December 31, 2020 | 5.00M |
| September 30, 2020 | 3.807M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amprius Technologies, Inc. | 4.099M |
| Eos Energy Enterprises, Inc. | 10.50M |
| ESS Tech, Inc. | 2.201M |
| Ultralife Corp. | 2.962M |
| Bimergen Energy Corp. | -- |